By Marilynn Larkin

NEW YORK (Reuters Health) – Individualizing radiotherapy according to levels of a patient-specific biomarker of liver function safely achieves local control in cancer patients at high risk for liver damage, researchers say.

Read More

News

By Marilynn Larkin

NEW YORK (Reuters Health) – Individualizing radiotherapy according to levels of a patient-specific biomarker of liver function safely achieves local control in cancer patients at high risk for liver damage, researchers say.

Read More

By Shereen Lehman

(Reuters Health) - Death rates from liver cancer in the U.S. have doubled since the 1980s and continue to rise, largely due to risk factors like hepatitis that should be the focus of better treatment and prevention efforts, researchers say.

Read More

By Marilynn Larkin

NEW YORK (Reuters Health) - Curative therapies are more likely to be prescribed when liver cancer patients are evaluated by a multidisciplinary team of specialists such as hepatologists, oncologists or surgeons, rather than general gastroenterologists, researchers say.

Read More

By David Douglas

NEW YORK (Reuters Health) - A simplified prognostic score may increase the accuracy of survival prediction after hepatectomy for intrahepatic cholangiocarcinoma (ICC), according to California-based researchers.

Read More

Research in Review

A study of image-guided percutaneous liver biopsy (PLB) in patients with hepatocellular carcinoma has found that the procedure is increasingly being used in recent years despite safety concerns as well as rising costs associated with the procedure. 

Read More

Subscribe to Liver Cancer